A Trial of Chemo & Radiation Therapy for Pancreatic Cancer
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label, non-randomized, combination study of cetuximab, gemcitabine, 5-FU, and
external beam radiotherapy in patients with locally advanced, non-metastatic pancreatic
cancer.